-- 周四,加拿大皇家银行资本市场(RBC Capital Markets)、加拿大帝国商业银行资本市场(CIBC Capital Markets)和道明证券(TD Securities)的分析师上调了Aecon集团(ARE.TO)的目标股价。 这家加拿大建筑和基础设施公司于周三公布了第一季度业绩。 Aecon股价在多伦多证券交易所上涨1.87加元,涨幅3.9%,收于49.97加元。 加拿大皇家银行分析师Sabahat Khan将该股的目标股价从44加元上调至49加元,并维持“与行业持平”的评级。 Khan在给客户的报告中表示:“总体而言,2026年开局良好,创纪录的109亿美元积压订单为公司发展创造了有利条件。” “随着营收持续增长,中期内,我们将密切关注利润率的提升(随着公司逐步摆脱传统项目的影响)。” 加拿大帝国商业银行分析师Krista Friesen将该股的目标股价从48加元上调至52加元,并维持“中性”评级。 弗里森在给客户的报告中表示:“我们认为(周三的)股价波动反映出投资者关注点已从近几个季度困扰公司的运营问题转向未来的机遇。” 道明银行分析师迈克尔·图普霍尔姆将目标价从59美元上调至62美元,并维持“买入”评级。 图普霍尔姆在给客户的报告中表示:“随着遗留项目风险基本消除,以及业务结构持续向结构性有吸引力的终端市场转型(尽管ARE的估值尚未完全反映这一点),我们预计其估值将进一步上调。” “与拥有类似吸引力的终端市场敞口的美国同行相比,ARE的股价仍然存在显著折让。”
Related Articles
Research Alert: The Clorox Company Beats Estimates Driven By Household And International
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:CLX reported Q3 FY 26 net sales of $1.67B, flat Y/Y with organic sales down 1%, while adj. EPS of $1.64 grew 13% and beat consensus by $0.10. Gross margin contracted 140 bps to 43.2% due to elevated manufacturing costs and unfavorable mix, though disciplined expense management supported earnings. Mixed segment performance showed Household and International delivering growth of 3% and 8%, respectively, while Lifestyle declined 9% on lower consumption and inventory adjustments. Management updated FY 26 guidance expecting net sales to decline ~6% with organic sales down ~9%, including a 7.5%-pt ERP headwind. Adj. EPS guidance of $5.45-$5.65 represents a 27%-29% decline, with gross margin expected to contract 250-300 bps from GOJO inventory step-up and elevated energy costs. The April 1 GOJO acquisition expands the health portfolio though near-term integration costs pressure results. We believe the completed $580M digital transformation positions CLX for long-term operational improvements despite macro headwinds.
Research Alert: Rivn: Q1 Eps Ahead Of Consensus; 2026 Guidance Unchanged
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Rivian (RIVN) posted Q1 adjusted EPS of -$0.55 vs. -$0.41, ahead of the -$0.60 consensus. Revenue rose 11% to $1.38B ($10M ahead of consensus) on a 20% increase in total vehicle sales to 10,365 units, augmented by a 49% Y/Y increase in software and services revenue to $473M. RIVN's gross margin contracted 800 bps to 8.6%, but was ahead of the 8.4% consensus. The quarter's financial results reflect the company's strategic pivot toward broader market accessibility with the R2, though at the cost of near-term profitability. RIVN maintained prior 2026 guidance for adjusted EBITDA, vehicle deliveries, and capex. The company ended Q1 with cash of $4.8B, down from $6.1B at year-end 2025. Shares are trading 1% higher in after-hours trading. RIVN's Q1 earnings were ahead of expectations, although cash burn remains a key concern, with free cash flow deteriorating, driven by increased operating expenses and working capital consumption. Execution risks remain high given challenging demand facing the broader EV industry.
Tanger Q1 Core FFO, Revenue Rise; 2026 Guidance Increased
Tanger (SKT) reported Q1 core funds from operations late Thursday of $0.59 per diluted share, up from $0.53 a year earlier.Analysts polled by FactSet expected $0.58.Revenue in the three months ended March 31 rose to $150.4 million from $135.4 million a year earlier.Analysts surveyed by FactSet expected $142.9 million.The company raised 2026 FFO guidance to $2.42 to $2.50 per diluted share from $2.41 to $2.49.Analysts polled by FactSet expect $2.47.Tanger shares fell 2.3% in after-hours trading.